Skip to content

Behavioural and Physiological Responses to Dog Visits in Nursing Homes

Behavioural and Physiological Responses to Dog Visits in Nursing Homes

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05516264
Enrollment
50
Registered
2022-08-25
Start date
2022-09-05
Completion date
2025-12-31
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Mood, Physiological Responses

Keywords

Human-animal contact, Non-invasive measure

Brief summary

In brief the study aims to investigate how nursing home residents receiving dog visits respond to contact with the dog, by comparing visits with and without a dog present. The investigators will measure the response with non-invasive measures of the immediate physiological response, and objective behavioural measurements to quantity the activity and the actual amount and intensity of contact to the dog.

Detailed description

The residents will receive six 10-minute visits, three visits with a dog and three without a dog, with a week-long break in between the two visit types. The participants will be randomly assigned to receive either the three dog visits or the three visits without a dog first. The visits will be from the same person, and the dog visits will be accompanied with the same dog each time. During dog visits, the dog will be available for touch, and the resident will be encouraged to interact with the dog. Before each visit the resident is fitted with the equipment for measuring continuously recorded physiological measures and then relaxes for 30 minutes. Immediately before and five and 30 minutes after each visit, the investigators obtain a saliva sample to detect cortisol levels. The behaviour of the participants will be video recorded during the visits to quantify the frequency and duration of predefined behavioural elements, using ethological methodology. The investigators will quantify the participants' activity during the visits as well as the frequency and duration of tactile contact with the dog, and verbal communication with the dog and the visitor. In addition, the visitor and the observer present during the visit will subjectively assess the resident's perception of the visit.

Interventions

BEHAVIORALDog visits/control visits

See arm description above

BEHAVIORALControl visits/dog visits

See arm description above

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants from 2 nursing homes (25+25) are all receive three visit with a dog and three without a dog. It is randomised whter participents receive the dog visits first or last.

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age of 65 years or more * Able to sit during visits (either in a chair or in a bed)

Exclusion criteria

* Known allergy to dogs * Known fear of dogs

Design outcomes

Primary

MeasureTime frameDescription
Heart rateDuring visit no. 1, from 30 minutes before the visit to 30 minutes afterThe test person wears a device placed on the upper arm
Heart rate variabilityDuring visit no. 1, from 30 minutes before the visit to 30 minutes afterHeart rate variability is calculated from heart rate data
Behaviour during visitsDuring visit no. 1, from 30 minutes before the visit to 30 minutes afterThe test persons behaviour is observed
Salivary cortisolVisit 1, 2 minutes before visitSaliva is obtained from the testperson with a swab which held his/her mouth for one minute

Secondary

MeasureTime frameDescription
The visitor's and observer's perception of how the visit was experienced by the test person.5 minutes after visit 1Minimum value 0 (worst possible visit) to 100 (best possible visit)
Visual analoque scale of the testpersons' evaluation of the visit5 minutes after visit 1Minimum value 0 (worst possible experience) to 100 (best possible experience)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026